Explore our blogs on various markets

Beyond Air, Inc. (NASDAQ: XAIR) has submitted a premarket approval (PMA) supplement to the U.S. Food and Drug Administration (FDA) for its second-generation LungFit PH II system....

The U.S. Food and Drug Administration (FDA) has approved BRINSUPRI™ (brensocatib), making it the first and only therapy for non-cystic fibrosis bronchiectasis (NCFB). . This chronic lung disease affects more than 500,000 people in the United States and has long been without an approved treatment option....

Cell and gene therapies (CGTs) represent a new frontier in healthcare. These treatments aim to modify or replace cells and genes to treat or cure diseases that were previously untreatable. . While their promise is enormous, launching them is not simple...

Running oncology clinical trials in the US is complex and resource-heavy. Patient recruitment, biomarker testing, data collection, and regulatory reporting all demand specialized expertise. Pharmaceutical companies and biotech sponsors often rely on Contract Research Organizations (CROs) to manage parts or all of the trial process....

Regulation shapes every part of the pharmaceutical industry. Agencies like the WHO, FDA (US), EMA (EU), MHRA (UK), ANVISA (Brazil), NMPA (China), and CDSCO (India) control how drugs are researched, developed, manufactured, and approved.. In 2025, these authorities are updating their frameworks to keep pace with artificial intelligence, digital health, advanced clinical trial models, sustainability rules, and global supply chain standards....

Pharma companies spend billions every year trying to influence doctors, patients, and healthcare systems. Yet clinical data and product claims alone often fail to change outcomes. People rely on habits, emotions, social cues, and mental shortcuts, not just logic. ...

Vaccines are biological products that protect people from infectious diseases by stimulating the body’s immune system. They are one of the most effective tools in public health, reducing illness, saving lives, and lowering healthcare costs.. The demand for vaccines is increasing worldwide due to government immunization programs, new biotechnology platforms like mRNA, and a growing need to prevent both infectious and chronic diseases....

Pharma R&D efficiency is under constant review by executives, investors, and regulators. The cost of bringing a new drug to market has increased, while success rates in clinical trials remain low. At the same time, pressure from pricing reforms, patent expiries, and investor expectations is forcing companies to do more with less....

Cell and gene therapies are changing modern medicine, offering new hope for patients with cancer, genetic disorders, and rare diseases. However, the success of these treatments depends on reliable and scalable manufacturing. Current processes are often complex, slow, and dependent on manual steps that introduce risks....

Daré Bioscience is set to launch DARE to PLAY™ Sildenafil Cream, the first evidence-backed topical treatment for female sexual arousal, in late 2025. Partnering with Rosy Wellness, the company has begun an awareness campaign to reduce stigma and provide women with trusted education and support around sexual health.. A Major Step Forward in Women’s Health...